Former Takeda Vaccine Chief to Lead New COVID Antiviral Venture Aerium

Aerium Therapeutics, a venture-backed startup, on Tuesday announced industry veteran Rajeev Venkayya will lead the company.
Reuters Health Information

source https://www.medscape.com/viewarticle/970702?src=rss

Comments

Popular posts from this blog

Student Nurses Who Refuse Vaccination Struggle to Complete Degrees

The Clinical Characteristics of Fractures in Pediatric Patients Exposed to Proton Pump Inhibitors